Corbus Pharmaceuticals Holdings, Inc. Stock
Stocks
CRBP
US21833P3010
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.260 USD | +2.61% |
|
+6.17% | +1.47% |
| 06-17 | Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $52 From $54, Maintains Outperform Rating | MT |
| 06-01 | Corbus Pharmaceuticals Holdings, Inc. - Special Call |
| Market Cap | 153M 133M 123M 116M 216M 14.42B 218M 1.46B 568M 7.11B 574M 562M 24.64B | P/E 2026 * |
-1.77x | P/E 2027 * | -1.56x |
|---|---|---|---|---|---|
| Enterprise Value | 153M 133M 123M 116M 216M 14.42B 218M 1.46B 568M 7.11B 574M 562M 24.64B | EV / Sales 2026 * |
138x | EV / Sales 2027 * | 63.8x |
| Free-Float |
98.92% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Corbus Pharmaceuticals Holdings, Inc.
| 1 day | +2.61% | ||
| 1 week | +6.17% | ||
| Current month | +4.42% | ||
| 1 month | -16.98% | ||
| 3 months | -8.73% | ||
| 6 months | +1.98% | ||
| Current year | +1.47% |
| 1 week | 7.87 |  | 8.57 |
| 1 month | 7.12 | | 12.88 |
| Current year | 7.12 | | 12.88 |
| 1 year | 6.72 | | 20.56 |
| 3 years | 3.03 | | 61.9 |
| 5 years | 2.11 | | 62.7 |
| 10 years | 2.11 | | 323.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuval Cohen
CEO | Chief Executive Officer | 51 | 2014-04-10 |
Sean Moran
DFI | Director of Finance/CFO | 68 | 2014-04-10 |
Ian Hodgson
COO | Chief Operating Officer | 53 | 2025-03-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Yuval Cohen
BRD | Director/Board Member | 51 | 2014-04-10 |
John Jenkins
BRD | Director/Board Member | 68 | 2018-06-04 |
Rachelle Jacques
CHM | Chairman | 54 | 2025-05-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-09 | Sell | Director | -2,412 | 0.0130% | ||
| 06-09 | Sell | Director | -4,800 | 0.0259% | ||
| 06-09 | Sell | Director | -2,026 | 0.0109% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.61% | +6.17% | -0.60% | +11.02% | 153M | |
| +0.63% | -2.04% | +62.21% | +113.16% | 54.44B | |
| +4.60% | +5.82% | +56.35% | +43.04% | 45.8B | |
| -1.44% | +1.51% | -12.94% | -19.24% | 22.98B | |
| -2.69% | -0.95% | -3.68% | +379.00% | 20.76B | |
| +3.22% | +2.94% | +24.02% | -35.05% | 16.25B | |
| +0.58% | +1.08% | +16.73% | -38.06% | 15.34B | |
| -1.01% | -2.97% | +27.42% | +171.92% | 13.05B | |
| +3.07% | +5.43% | +21.37% | - | 12.37B | |
| +4.95% | +13.49% | +121.11% | +249.05% | 12.47B | |
| Average | +1.45% | +2.42% | +31.20% | +97.21% | 21.36B | |
| Weighted average by Cap. | +1.42% | +1.39% | +39.19% | +98.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.11M 968K 892K 839K 1.57M 105M 1.58M 10.62M 4.12M 51.61M 4.17M 4.08M 179M | 2.4M 2.09M 1.93M 1.81M 3.39M 226M 3.42M 22.93M 8.91M 111M 9.01M 8.82M 386M |
| Net income | -97.64M -85.07M -78.42M -73.76M -138M -9.2B -139M -933M -362M -4.53B -366M -359M -15.72B | -123M -107M -98.43M -92.58M -173M -11.55B -174M -1.17B -455M -5.69B -460M -450M -19.73B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 8.260 $ | +2.61% | 297,815 |
| 26-06-17 | 8.050 $ | +2.16% | 279,017 |
| 26-06-16 | 7.880 $ | -5.29% | 482,852 |
| 26-06-15 | 8.320 $ | +1.59% | 335,487 |
| 26-06-12 | 8.190 $ | +5.27% | 574,890 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRBP Stock
Select your edition
All financial news and data tailored to specific country editions
